Database collecting clinical data from people treated for bladder cancer
Collects medical and tissue data from adults treated for urothelial bladder cancer.
Plain-language title generated from the registry record
Registry title: Prospective Sample Collection for Cancer of Bladder
Key facts
- Where
- Leuven, BelgiumSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT03973671, who can take part
Where in Belgium
- University Hospitals LeuvenLeuven, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitaire Ziekenhuizen KU Leuven
- Trial code
- NCT03973671
- Record updated
- 28 March 2024
- Original description
The goal of the Flemish Databank for Urothelial Cancer is to collect clinical and pathological data of patients treated for urothelial cancer (UC).Read full original descriptionShow less
Flemish Prospective Clinical and Pathological Database for Urothelial Cancer
The goal of the Flemish Databank for Urothelial Cancer is to collect clinical and pathological data of patients treated for urothelial cancer (UC).
Inclusion: who are aged between 18-90,; who are of male or female sex,; who give their informed consent to collect their clinical and pathological data,; who are planned to undergo TURBT for BC,; who are planned to undergo (salvage) radical cystectomy with or without an extended pelvic lymph node dissection,; who are planned to undergo tumor biopsy (from primary or metastatic tumor),; who are planned to undergo radical nephroureterectomy ± partial cystectomy or segmental ureterectomy, with or without a lymph node dissection,; who are planned to undergo endoscopic tumor biopsy or resection,; from whom metastases will be surgically removed.
Exclusion: patients who do not give their informed consent to collect their clinical and pathological data,; patients who withdraw their informed consent to use their clinical and pathological data,; patients who refuse the planned treatment,; women who are pregnant or have suspicion of pregnancy.